Merck says deal signed with Singapore on COVID-19 antiviral pill
Though Singapore's health ministry did not immediately confirm the deal, it would be the fourth country to enter talks of purchase with Merck.
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.(photo credit: MERCK & CO INC/HANDOUT VIA REUTERS)
